• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Procyrion

How to design medtech clinical trials that deliver

March 25, 2025 By Scott Nelson

Transparent, well-designed clinical trials are a must. Here’s advice on how to get there. Scott Nelson, co-founder and CEO of FastWave Medical Dozens of medical devices annually make it onto the FDA’s list of the newest approved medtech. Yet, alongside this progress, the agency faces a stark reality: over the last decade, faulty devices have been […]

Filed Under: Blog, Business/Financial News, Clinical Trials, Featured Tagged With: Adona Medical, FastWave Medical, Instylla, Mainstay Medical, medsider, Procyrion, VenoStent

Procyrion adds Silk Road Medical exec to its board

September 9, 2024 By Chris Newmarker

Procyrion — developer of the catheter-deployed Aortix percutaneous mechanical circulatory support device — has a new board member. Lucas Buchanan is the COO of Sunnyvale, California–based Silk Road Medical. Boston Scientific is in the process of acquiring Silk Road and its technology to prevent stroke in patients with carotid artery disease in a $1.16 billion […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured Tagged With: Personnel Moves, Procyrion, Silk Road Medical

Procyrion raises $57.7M Series E for circulatory support device

February 5, 2024 By Sean Whooley

Procyrion announced today that it completed a $57.7 million Series E funding round to support its Aortix device. Fannin Partners led the round, which included the conversion of $10 million in interim financing. New and existing family/multi-family office investors partnered with Fannin Partners in the financing. Returning investors, including BlueBird Ventures and an undisclosed strategic […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Funding Roundup, Structural Heart, Vascular Tagged With: Procyrion

Procyrion enrolls first patient in IDE trial for mechanical circulatory support tech

November 30, 2023 By Sean Whooley

Procyrion announced today that it enrolled the first patient in its investigational device exemption trial of the Aortix system. The DRAIN-HF study evaluates the Aortix percutaneous mechanical circulatory support (pMCS) technology. Patients in the trial present acute decompensated heart failure (ADHF) and remain unresponsive to standard medical therapy. Dr. Bassem Chehab enrolled the first patient […]

Filed Under: Blood Management, Cardiovascular, Clinical Trials, Structural Heart, Vascular Tagged With: Procyrion

Aortix circulatory support device from Procyrion produces positive study results

March 21, 2023 By Sean Whooley

Procyrion today announced study results demonstrating that use of its Aortix device led to rapid decongestion in a pilot study. Houston-based Procyrion evaluated Aortix percutaneous mechanical circulatory support (pMCS) pump in patients with acute decompensated heart failure (ADHF) and worsening renal function. This is known as cardiorenal syndrome (CRS). The pump patients — unresponsive to […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Structural Heart Tagged With: Procyrion, THT 2023

Procyrion raises $30m Series D for Aortix heart pump

July 11, 2019 By Danielle Kirsh

Procyrion said this week that it closed a $30 million Series D round for its Aortix percutaneous blood pump. The Aortix blood pump is designed to treat patients with heart failure and worsening kidney function. The pump is thinner than a pencil and can be placed in less than 10 minutes during a cath-lab procedure. […]

Filed Under: Cardiac Implants, Cardiovascular, Funding Roundup Tagged With: Procyrion

ViewRay picks up ex-Spectranetics CEO Drake, COO Matin | Personnel Moves – July 25, 2018

July 25, 2018 By Fink Densford

ViewRay (NSDQ:VRAY) said yesterday it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO. Before joining ViewRay, Drake served as CEO and prez of Spectranetics, which was acquired by Royal Philips (NYSE:PHG) in a deal that closed last August. Drake also serves as board chair […]

Filed Under: Business/Financial News Tagged With: Alphabet (Google), avitamedical, Bonesupport, Clinical Innovations, intentsolutions, ohiomedical, Olympus, Personnel Moves, Philips, Procyrion, Spectranetics Corp., ViewRay Inc.

Procyrion raises $16m in Series C to support Aortix intra-aortic heart pump

February 1, 2018 By Fink Densford

Procyrion said earlier this week it raised $16 million in a Series C round of funding to support its Aortix catheter-deployed, intra-aortic heart pump designed for ambulatory use. The round was led by an affiliate of Fannin Partners and joined by existing investors Scientific Health Development, the State of Texas and an undisclosed strategic investor, […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular Tagged With: Procyrion

Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

December 17, 2015 By Brad Perriello

Cardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO. Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) […]

Filed Under: Business/Financial News Tagged With: Cardiac Dimensions Inc., Cellnovo, Delphinus Medical Technologies Inc., dextera, Femasys Inc., Grifols, Masimo, NVision, Personnel Moves, Procyrion, Signostics

Procyrion’s Aortix device could heighten heart pump competition

October 22, 2015 By Mark Hollmer

Pay attention to Procyrion over the next several months. CEO Benjamin Hertzog tells MassDevice.com that the company plans on heading to the clinic with a device that could heighten competition among makers of cardiac assist devices. The Houston-based startup plans to begin 1st-in-human trials of its Aortix catheter-based heart pump in the 1st half of 2016. […]

Filed Under: Structural Heart Tagged With: Abiomed, Procyrion

Procyrion drums up $10m Series B for Aortix heart pump

October 9, 2015 By Brad Perriello

Procyrion said it raised a $10 million Series B round for its Aortix heart pump, led by the consortium of Fannin Partners, Scientific Health Development and an unnamed strategic investor. Prior backers and new investors also participated, Houston-based Procyrion said. The Aortix pump is designed to use a principle called fluid entrainment to help unburden the heart muscle. Unlike […]

Filed Under: Cardiovascular, Funding Roundup, Structural Heart Tagged With: Procyrion

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy